Pharmacokinetic and pharmacodynamic considerations with psychiatric disorders and migraines.
作者信息
Palmer Emma C, Shuman Michael D, Oiler Isabelle G
机构信息
Clinical Staff Pharmacist, Central State Hospital, Louisville, Kentucky.
PGY1 Pharmacy Resident, University of Cincinnati, West Chester Hospital, West Chester Township, Ohio.
出版信息
Ment Health Clin. 2024 Jun 3;14(3):195-198. doi: 10.9740/mhc.2024.06.195. eCollection 2024 Jun.
Abstract
摘要
相似文献
1
Pharmacokinetic and pharmacodynamic considerations with psychiatric disorders and migraines.
Ment Health Clin. 2024 Jun 3;14(3):195-198. doi: 10.9740/mhc.2024.06.195. eCollection 2024 Jun.
2
Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 6: Pharmacodynamic Considerations.
J Psychiatr Pract. 2019 Jul;25(4):290-297. doi: 10.1097/PRA.0000000000000399.
3
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis.
Clin Pharmacokinet. 2024 Feb;63(2):137-153. doi: 10.1007/s40262-023-01341-4. Epub 2024 Jan 27.
4
Pharmacokinetic/pharmacodynamic considerations for cancer patients undergoing hemodialysis.
Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):617-623. doi: 10.1080/17425255.2017.1292252. Epub 2017 Feb 17.
5
Prevalence of migraine and co-morbid psychiatric disorders among students of Cumhuriyet University.
J Headache Pain. 2013 Apr 11;14(1):34. doi: 10.1186/1129-2377-14-34.
6
Antibiotic pharmacokinetic and pharmacodynamic considerations in patients with kidney disease.
Adv Chronic Kidney Dis. 2010 Sep;17(5):392-403. doi: 10.1053/j.ackd.2010.05.007.
7
Pharmacodynamic and pharmacokinetic considerations in choosing an inhaled corticosteroid.
Treat Respir Med. 2006;5(4):245-53. doi: 10.2165/00151829-200605040-00003.
8
Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
Int Rev Neurobiol. 2008;83:397-416. doi: 10.1016/S0074-7742(08)00022-6.
9
Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?
Expert Opin Drug Metab Toxicol. 2012 Feb;8(2):141-60. doi: 10.1517/17425255.2012.643868. Epub 2012 Jan 17.
10
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.
Clin Pharmacokinet. 2013 Oct;52(10):869-83. doi: 10.1007/s40262-013-0086-1.
本文引用的文献
1
Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?
J Clin Psychopharmacol. 2024;44(2):199-200. doi: 10.1097/JCP.0000000000001812. Epub 2024 Jan 15.
2
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience.
Front Neurol. 2023 Oct 27;14:1291102. doi: 10.3389/fneur.2023.1291102. eCollection 2023.
3
Calcitonin gene relating peptide inhibitors in combination for migraine treatment: A mini-review.
Front Pain Res (Lausanne). 2023 Mar 17;4:1130239. doi: 10.3389/fpain.2023.1130239. eCollection 2023.
4
Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review.
Health Psychol Res. 2022 Nov 3;10(4):39580. doi: 10.52965/001c.39580. eCollection 2022.
5
Topiramate-Related Hyperammonemia.
J Pharm Technol. 2016 Feb;32(1):34-36. doi: 10.1177/8755122515605849. Epub 2015 Sep 11.
6
What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics.
Rev Neurol (Paris). 2021 Sep;177(7):821-826. doi: 10.1016/j.neurol.2021.07.007. Epub 2021 Jul 27.
7
A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management.
Headache. 2021 Jun;61(6):838-853. doi: 10.1111/head.14135.
8
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.
Headache. 2021 Jul;61(7):1021-1039. doi: 10.1111/head.14153. Epub 2021 Jun 23.
9
Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019.
Pain. 2022 Feb 1;163(2):e293-e309. doi: 10.1097/j.pain.0000000000002275.
10
Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials.
J Psychopharmacol. 2021 Aug;35(8):910-918. doi: 10.1177/0269881121991827. Epub 2021 Mar 15.
Zotero 插件